Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Breast Cancer (LABC)”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Not applicableNot Yet RecruitingNCT07570368
What this trial is testing

Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasm FemaleLocally Advanced Breast Cancer (LABC)+1 more
Universitas Airlangga 54
Not applicableLooking for participantsNCT06080620
What this trial is testing

The Choice of Treatment Methods and Efficacy of LABC

Who this might be right for
Locally Advanced Breast Cancer
Peking Union Medical College Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07336771
What this trial is testing

JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast Cancer (LABC)
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 60
Testing effectiveness (Phase 2)Study completedNCT02280252
What this trial is testing

Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response

Who this might be right for
Breast Cancer
NYU Langone Health 69
Early research (Phase 1)Study completedNCT01471847
What this trial is testing

A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab

Who this might be right for
Locally Advance Breast Cancer (LABC)Metastatic Breast Cancer (MBC)
Novartis Pharmaceuticals 5
Not applicableStudy completedNCT03732339
What this trial is testing

CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical Trial

Who this might be right for
Locally Advanced Breast CancerCirculating Tumor Cell
RenJi Hospital 29
Large-scale testing (Phase 3)UnknownNCT02404051
What this trial is testing

Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerBreast CancerHormone Receptor Positive Tumor+2 more
Consorzio Oncotech 745
Large-scale testing (Phase 3)Ended earlyNCT04740918
What this trial is testing

Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Hoffmann-La Roche 96
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07189884
What this trial is testing

Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy

Who this might be right for
Locally Advanced Breast Cancer (LABC)
The First Affiliated Hospital of Xiamen University 33
Not applicableStudy completedNCT00788489
What this trial is testing

A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant Chemotherapy

Who this might be right for
Locally Advanced Breast Cancer
Ontario Clinical Oncology Group (OCOG) 49
Not applicableNot Yet RecruitingNCT07420335
What this trial is testing

Preoperative Shoulder Exercises and Postoperative Inflammation, Pain, and Function After Modified Radical Mastectomy

Who this might be right for
Locally Advanced Breast Cancer (LABC)Postoperative InflammationPrehabilitation
Indonesia University 52
Testing effectiveness (Phase 2)Study completedNCT00286247
What this trial is testing

Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer

Who this might be right for
Locally Advanced Breast Cancer (LABC)
Introgen Therapeutics 60
Early research (Phase 1)WithdrawnNCT07150767
What this trial is testing

A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) Combined With Neoadjuvant Treatment for Locally Advanced Breast Cancer

Who this might be right for
Locally Advanced Breast Cancer (LABC)
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Early research (Phase 1)Ended earlyNCT06878248
What this trial is testing

Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer MetastaticLocally Advanced Breast Cancer (LABC)Malignant Neoplasm of Breast+3 more
Calibr, a division of Scripps Research 10
Early research (Phase 1)Ended earlyNCT01805908
What this trial is testing

Imaging With 111 Indium (111In)-Pertuzumab (PmAb) to Predict Response to Trastuzumab (TmAb) in Human Epidermal Growth Factor-2 (HER2) Positive Metastatic Breast Cancer (MBC) or Locally Advanced Breast Cancer (LABC)

Who this might be right for
Breast Cancer
Ontario Clinical Oncology Group (OCOG) 3
Not applicableNot Yet RecruitingNCT07516626
What this trial is testing

Patient-Derived Organoids to Functionally Characterize Chemotherapy Resistance in Breast Cancer

Who this might be right for
Breast CancerLocally Advanced Breast Cancer (LABC)
Atlas University 40
Not applicableStudy completedNCT01240681
What this trial is testing

Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) and Fluorothymidine Positron Emission Tomography (FLT PET) in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy

Who this might be right for
Locally Advanced Breast Cancer (LABC)
Ontario Clinical Oncology Group (OCOG) 32
Testing effectiveness (Phase 2)Study completedNCT00044993
What this trial is testing

Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Introgen Therapeutics
Not applicableLooking for participantsNCT04050228
What this trial is testing

Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast Cancer

Who this might be right for
Breast Cancer
Sunnybrook Health Sciences Centre 240
Testing effectiveness (Phase 2)Looking for participantsNCT07002177
What this trial is testing

A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC

Who this might be right for
Metastatic Breast CancerBreast Cancer Stage IBreast Cancer Stage II+2 more
Forward Pharmaceuticals Co., Ltd. 196